We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PLOW:NYSEDouglas Dynamics, Inc. Analysis

Data as of 2026-08-21 - not real-time

$42.18

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Douglas Dynamics, Inc. is neutral at $42.18, with no clear ordering between short and long averages. It has lost 1.9% over the past 30 days. RSI sits at 43.4, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $38.68 up to resistance at $46.29.
Valuation screens as fair, on a P/E of 19.2 with no clean sector comparison available. Analyst price targets sit 28.0% above the current price. Revenue is growing at 10.5% on a 7.5% profit margin. The 2.87% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 38.0%, a beta of 0.94 and a maximum drawdown of 24.2%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 5/10 conviction on the long call.

Top Market Events

Snow and ice equipment company Douglas Dynamics NYSE:PLOW in Q2 CY2026, but sales rose 10.MILWAUKEE, July 21, 2026 GLOBE NEWSWIRE -- Douglas Dynamics, Inc.MILWAUKEE, July 21, 2026 GLOBE NEWSWIRE -- Douglas Dynamics, Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 41.21
  • MACD momentum is negative
  • Maximum drawdown of 24.2%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 41.21
  • Analyst targets imply +28.0% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +28.0% versus the current price
  • Revenue growth of +10.5%
  • P/E ratio of 19.2

Key Metrics & Analysis

Financial Health

Revenue Growth10.50%
Profit Margin7.52%
P/E Ratio19.2
ROE18.34%
ROA7.05%
Debt/Equity96.95
P/B Ratio3.5
Op. Cash Flow$62.2M
Free Cash Flow$34.3M

Technical Analysis

TrendNeutral
RSI43.4
Support$38.68
Resistance$46.29
MA 20$43.07
MA 50$45.73
MA 200$41.21
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

Fair Value$17.10
Target Price$54.00
Upside/Downside28.02%
GradeFair
TypeBlend
Dividend Yield2.87%

Risk Assessment

Beta0.94
Volatility38.00%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.